Allergan Inc $168.21

down -1.76


19/9/2014 04:00 PM  |  NYSE : AGN  
Industries : Drugs / Drug Manufacturers - Other
Get Trend Analysis Icon Get AGN Trend Analysis - it has outperformed the S&P 500 by 75%

Partner Headlines

  1. Auxilium Mulls Endo Bid; Is $2.2 Billion Enough?

    IBD
  2. Auxilium Mulls Endo Bid; Street Eyes A Higher Price

    IBD
  3. Valeant, Allergan settle suit

    IBD
  4. Valeant, Allergan Settle Suit, Allow Shareholder Vote

    IBD
  5. Ackman's New Fund Could Spur More Market Activism

    IBD
  6. Pershing Square Submiterd Additional Special Meeting Requests On Friday, ...

    Benzinga
  7. Gilead, Jazz, Salix Among Top 6 IBD 50 Drugmakers

    IBD
  8. Allergan Comments On Pershing Square's Delivery Of Additional Requests ...

    Benzinga
  9. Bill Ackman Rips Allergan, Inc. In Letter

    Benzinga
  10. William Ackman Sends Letter To Allergen Board

    Benzinga
  11. Salix, Gilead Among 5 Top Medical Leaders To Watch

    IBD
  12. Jazz Pharmaceuticals Up On Allergan, Inc. Rumor

    Benzinga
  13. Stocks Rise, Turn Positive Going Into Final Hour

    IBD
  14. Three Stocks Top-Performing Funds Like: Facebook Baidu Gilead

    IBD
  15. Allergan Reports Filing of Answer in Federal Court Related to Valeant, ...

    Benzinga
  16. Gilead, Jazz Among 4 Top Big Cap Medicals To Watch

    IBD
  17. S&P 500 Closes Above 2,000; Dow Hits New All-Time High As Markets Continue ...

    Benzinga
  18. 3 Pharma Companies That Could Deliver Breakthroughs In 'Plantibody' Technology

    Benzinga
  19. Yellen's Speech Not Enough To Keep Dow, S&P 500 In Positive Territory

    Benzinga
  20. S&P 500 Marks New High As Indexes Hold Gains

    IBD
  21. SALIX PHARMACEUTICALS

    IBD
  22. Major Indexes Turn Mixed; Jazz Pharmaceuticals Turns Up

    IBD
  23. Benzinga's M&A Chatter for Tuesday August 19, 2014

    Benzinga
  24. Salix Soars On Allergan Buzz

    IBD
  25. Indexes Rally On Strong Housing Data, Retail Reports

    IBD
  26. Dow Flirts With 19,000, S&P 500 Approaches 2,000 & Nasdaq Trading At 14-Year ...

    Benzinga
  27. Stocks Add To Gains; Salix Surges On Potential Bid

    IBD
  28. Allergan Reportedly Eyes Salix To Avoid Valeant Deal

    IBD
  29. Allergan On The Acquisition Hunt

    Benzinga
  30. JP Morgan Says Jazz Pharmaceuticals Positioned For 'Organic Growth And ...

    Benzinga
  31. Allergan

    IBD
  32. Allergan Takes In 13 New Hedge Fund Investments In Q2

    Benzinga
  33. Notable Hedge Funds Disclose Additions And Reductions To Holdings

    Benzinga
  34. Markets Gather Some Momentum As Volume Remains Light, Geopolitical Tension ...

    Benzinga
  35. Benzinga's M&A Chatter for Monday August 11, 2014

    Benzinga
  36. Valeant Pharmaceuticals'

    IBD
  37. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  38. Allergan

    IBD
  39. Allergan Rebounds After Analyst Upgrades On Valuation

    IBD
  40. Benzinga's Top Upgrades

    Benzinga
  41. Leerink Swann Upgrades Allergan To Outperform

    Benzinga
  42. Fast Money Picks For August 8

    Benzinga
  43. Top Performing Funds Play Favorits

    IBD
  44. Prescription Drugmakers Slide Down Industry Rankings

    IBD
  45. Thursday's Selling Momentum Continues In To Friday

    Benzinga
  46. Thursday's Selling Momentum Continues Into Friday

    Benzinga
  47. US M&A Announced Deals Surpass $1 Trillion For 2014

    Benzinga
  48. Valeant, Ackman's Pershing Square Issue Response to 'Frivolous Allergan ...

    Benzinga
  49. Valeant Guides Outlook Low

    IBD
  50. Dow Suffers 300 Point Drop; S&P 500 And Nasdaq Also Tumble

    Benzinga
Trading Center